From Molecular Insights to Novel Therapies: Neurological Diseases

Dear Colleagues,

Neurological diseases are a diverse group of central and peripheral nervous system pathologies, which together are one of the leading causes of morbidity and mortality worldwide. To date, the range of treatment options for neuropathologies is extremely limited, with rates reflecting the number of FDA-approved drugs remaining low compared to other pharmaceutical industries. The complexity of creating effective therapeutic strategies is due to the polyetiological nature of neurological diseases, which is manifested in the heterogeneity of pathogenetic mechanisms. The combination of these factors leads to an urgent need to identify new biomarkers and create innovative methods of treatment to solve this problem, which places a huge socio-economic burden on the healthcare system and society as a whole.

In this Special Issue, we do not want to limit the authors to only work in the field of neurodegenerative diseases (Alzheimer's disease, Parkinson's disease, etc.). Topics of interest also include mental illness, cerebrovascular, psychiatric, autoimmune-related, and traumatic diseases.

We will be sincerely glad to consider reviews of the latest achievements of highly qualified specialists in the neuroscience field, as well as experimental articles containing up-to-date information on the problems and prospects in the development of effective drugs for the various neurological disorder’s treatment.

Dr. Margarita Neganova
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• neurological diseases
• neurodegenerative diseases
• epilepsy
• mental illness
• transgenic animal models
• molecular pathways
• metabolism disabilities
• mitochondrial dysfunction
• oxidative stress
• disturbances in epigenetic regulation